Article
Human papillomavirus genotyping predicts residual/recurrent disease after local treatment for cervical intraepithelial neoplasia better than viral DNA testing.
The journal of obstetrics and gynaecology research - 1 Oct 2021
Kawano Kouichiro, Tsuda Naotake, Nasu Hiroki, Tasaki Shingo, Park Jongmyung, Tasaki Kazuto, Terada Atsumu, Nishio Shin, Ushijima Kimio
Abstract excerpt
AIM: Type-specific persistent infection (TSPI) of human papillomavirus (HPV) is reportedly associated with a high risk of residual/recurrent disease after local treatment for cervical intraepithelial neoplasia (CIN). This study aimed to evaluate whether HPV genotyping is more accurate in detectin...
Topics
- Alphapapillomavirus
- DNA, Viral
- Female
- Genotype
- Humans
- Papillomaviridae
- Papillomavirus Infections
- Retrospective Studies
- Uterine Cervical Neoplasms
- Uterine Cervical Dysplasia